Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations

por Yuan, Ji, He, Rong, Alkhateeb, Hassan B.
Publicado 2023

High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant

por Baranwal, Anmol, Mangaonkar, Abhishek, Shah, Mithun V., Litzow, Mark R., Hogan, William J., Patnaik, Mrinal M., Alkhateeb, Hassan B.
Publicado 2022

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

por Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
Publicado 2018

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

por Nadiminti, Kalyan, Sidiqi, M. Hasib, Meleveedu, Kapil, Alkhateeb, Hassan B., Hogan, William J., Litzow, Mark, Patnaik, Mrinal, Kumar, Shaji, Gertz, Morie, Chen, Dong, Shah, Mithun Vinod
Publicado 2021

Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia

por Baranwal, Anmol, Nanaa, Ahmad, Viswanatha, David, He, Rong, Foran, James, Badar, Talha, Hogan, William J., Litzow, Mark R., Shah, Mithun Vinod, Patnaik, Mrinal M., Al-Kali, Aref, Alkhateeb, Hassan B.
Publicado 2022

Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning

por Kutzke, Jade L., Merten, Julianna A., Pawlenty, Amanda G., Barreto, Erin F., Bartoo, Gabe T., Mara, Kristin C., Litzow, Mark R., Hogan, William J., Shah, Mithun V., Mangaonkar, Abhishek A., Leung, Nelson, Alkhateeb, Hassan B.
Publicado 2022

Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy

por Gangat, Naseema, Ilyas, Rimal, Johnson, Isla M., McCullough, Kristen, Al-Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Mangaonkar, Abhishek, Litzow, Mark R, Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Tefferi, Ayalew
Publicado 2023

Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents

por Johnson, Isla M., Bezerra, Evandro D., Farrukh, Faiqa, McCullough, Kristen, Al-Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede, Litzow, Mark R., Hogan, William J., Shah, Mithun Vinod, Patnaik, Mrinal M., Tefferi, Ayalew, Gangat, Naseema
Publicado 2022

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

por Xie, Zhuoer, Nanaa, Ahmad, Saliba, Antoine N., He, Rong, Viswanatha, David, Nguyen, Phuong, Jevremovic, Dragan, Greipp, Patricia, Salama, Mohamad E., Gangat, Naseema, Alkhateeb, Hassan B., Tefferi, Ayalew, Litzow, Mark, Patnaik, Mrinal, Shah, Mithun, Al-Kali, Aref
Publicado 2021

Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival

por Gangat, Naseema, Kuykendall, Andrew, Al Ali, Najla, Goel, Swati, Abdelmagid, Maymona, Al-Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Mangaonkar, Abhishek, Litzow, Mark R., Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Komrokji, Rami, Tefferi, Ayalew
Publicado 2023

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms

por Shah, Mithun Vinod, Chhetri, Rakchha, Dholakia, Ruchita, Kok, Chung H., Gangat, Naseema, Alkhateeb, Hassan B., Al‐Kali, Aref, Patnaik, Mrinal M., Baranwal, Anmol, Greipp, Patricia T., He, Rong, Begna, Kebede H., Tiong, Ing Soo, Wei, Andrew H., Hiwase, Devendra
Publicado 2022

Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience

por Nanaa, Ahmad, Viswanatha, David, Xie, Zhuoer, Jevremovic, Dragan, Nguyen, Phuong, Salama, Mohamad E., Greipp, Patricia, Bessonen, Kurt, Gangat, Naseema, Patnaik, Mrinal, Pardanani, Animesh, Alkhateeb, Hassan B., Shah, Mithun, Hogan, William, Tefferi, Ayalew, Litzow, Mark, He, Rong, Al-Kali, Aref
Publicado 2021

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

por Al-Kali, Aref, Nanaa, Ahmad, Viswanatha, David, He, Rong, Nguyen, Phuong, Jevremovic, Dragan, Foran, James M., Yi, Cecelia Arana, Greipp, Patricia T., Gangat, Naseema, Patnaik, Mrinal, Tefferi, Ayalew, Litzow, Mark R., Mangaonkar, Abhishek A., Shah, Mithun Vinod, Badar, Talha, Alkhateeb, Hassan B.
Publicado 2023

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

por Badar, Talha, Vanegas, Yenny A. Moreno, Nanaa, Ahmad, Foran, James M., Al-Kali, Aref, Mangaonkar, Abhishek, Murthy, Hemant, Alkhateeb, Hassan B., Viswanatha, David, He, Rong, Shah, Mithun, Yi, Cecilia Arana, Litzow, Mark R., Gangat, Naseema, Tefferi, Ayalew, Patnaik, Mrinal M.
Publicado 2023

Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma

por Acosta-Medina, Aldo A., Johnson, Isla McKerrow, Bansal, Radhika, Hathcock, Matthew, Kenderian, Saad J., Durani, Urshila, Khurana, Arushi, Wang, Yucai, Paludo, Jonas, Villasboas, Jose C., Bennani, N. Nora, Johnston, Patrick B., Ansell, Stephen M., Lin, Yi, Alkhateeb, Hassan B.
Publicado 2023

Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms

por Badar, Talha, Nanaa, Ahmad, Foran, James M., Viswanatha, David, Al-Kali, Aref, Lasho, Terra, Finke, Christy, Alkhateeb, Hassan B., He, Rong, Gangat, Naseema, Shah, Mithun, Tefferi, Ayalew, Mangaonkar, Abhishek A., Litzow, Mark R., Ongie, Laura J., Chlon, Timothy, Ferrer, Alejandro, Patnaik, Mrinal M.
Publicado 2023

Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms

por Alkhateeb, Hassan B., Nanaa, Ahmad, Viswanatha, David, Foran, James M., Badar, Talha, Sproat, Lisa, He, Rong, Nguyen, Phuong, Jevremovic, Dragan, Salama, Mohamad E., Greipp, Patricia, Gangat, Naseema, Tefferi, Ayalew, Litzow, Mark R., Mangaonkar, Abhishek A., Shah, Mithun Vinod, Patnaik, Mrinal, Al-Kali, Aref
Publicado 2022

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma

por Parrondo, Ricardo D., Rahman, Zaid Abdel, Heckman, Michael G., Wieczorek, Mikolaj, Jiang, Liuyan, Alkhateeb, Hassan B., Litzow, Mark R., Greipp, Patricia, Sher, Taimur, Bergsagel, Leif, Fonseca, Rafael, Roy, Vivek, Dispenzieri, Angela, Kharfan-Dabaja, Mohamed A., Murthy, Hemant S., Ailawadhi, Sikander, Foran, James M.
Publicado 2022

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms

por Shah, Mithun Vinod, Mangaonkar, Abhishek A., Begna, Kebede H., Alkhateeb, Hassan B., Greipp, Patricia, Nanaa, Ahmad, Elliott, Michelle A., Hogan, William J., Litzow, Mark R., McCullough, Kristen, Tefferi, Ayalew, Gangat, Naseema, Patnaik, Mrinal M., Al-Kali, Aref, He, Rong, Chen, Dong
Publicado 2022

Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience

por Katamesh, Bahga, Nanaa, Ahmad, He, Rong, Viswanatha, David, Nguyen, Phuong, Greipp, Patricia, Bessonen, Kurt, Gangat, Naseema, Begna, Kebede, Mangaonkar, Abhishek, Patnaik, Mrinal, Hogan, William J., Tefferi, Ayalew, Litzow, Mark, Shah, Mithun Vinod, Yi, Cecilia Arana, Foran, James, Badar, Talha, Alkhateeb, Hassan B., Al-Kali, Aref
Publicado 2022